The biological roles of YAP in malignant mesothelioma proliferation and invasion
The biological roles of YAP in malignant mesothelioma proliferation and invasion
批准号:
22590375
负责人:
MURAKAMI Hideki
金额:
$2.91万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012
中文摘要
我们最近发现恶性间皮瘤细胞系经常携带与Hippo肿瘤抑制通路相关的基因突变。Hippo通路的失调导致转录共激活因子yes相关蛋白(YAP)和带pdz结合基序的YAP类转录共激活因子(TAZ)的激活。然而,YAP/TAZ对MM细胞生长或运动的具体作用尚不清楚。为了研究YAP/TAZ在MM细胞发育中的生物学作用,我们在MM细胞中建立了慢病毒介导的YAP或TAZ敲除系统,并利用寡核苷酸芯片分析了细胞生长、运动和基因表达模式的变化。SiRNA介导的YAP/TAZ在MM细胞系中的减少抑制细胞增殖和运动。我们还发现,通过YAP/TAZ敲低,一些参与细胞增殖、凋亡和细胞骨架的基因被解除调控。我们的研究结果将为间皮瘤的发展提供新的见解,并为开发新的间皮瘤分子靶向治疗提供一些线索。
英文摘要
We recently revealed malignant mesothelioma cell lines frequently harbor mutations of the genes associated with Hippo tumor suppressor pathway. Dysregulation of Hippo pathway leads to activation of a transcriptional co-activator Yes-associated protein (YAP) and the YAP paralog transcriptional co-activator with PDZ-binding motif (TAZ). However the detailed function of YAP/TAZ on MM cell growth or motility remains unclear. To investigate the biological roles of YAP/TAZ in MM development, we generated lentivirus mediated YAP or TAZ knock-down system in MM cells, and analyzed the changes in cell growth, motility, and the gene expression patterns with oligonucleotide microarrays. SiRNA mediated reduction of YAP/TAZ in MM cell lines suppress cell proliferation and motility. We also detected the deregulation of several genes involved in cell proliferation, apoptosis, and cytoskeleton by YAP/TAZ knockdown. Our results will provide new insights into development of mesothelioma, and give some clues to developing a new molecular target therapy for mesothelioma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1158/0008-5472.can-10-2164
发表时间:
2011-02-01
期刊:
CANCER RESEARCH
影响因子:
11.2
作者:
[Murakami, Hideki, Mizuno, Tetsuya, Sekido, Yoshitaka]
通讯作者:
Sekido, Yoshitaka
Expression and functional analysis of Hairy Enhancer of Split 1 (HES1) in malignant mesothelioma cell lines
Hairy Enhancer of Split 1 (HES1)在恶性间皮瘤细胞系中的表达及功能分析
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Ohbayashi, T., Imamura, T., 村上秀樹]
通讯作者:
村上秀樹
DOI:
10.1016/j.canlet.2010.10.005
发表时间:
2011-01-28
期刊:
CANCER LETTERS
影响因子:
9.7
作者:
[Hwang, Ji-Hwan, Takagi, Motoki, Shin-ya, Kazuo]
通讯作者:
Shin-ya, Kazuo
Induction of tubulin polymerization and apoptosis in malignant mesothelioma cells by new compound JBIR-23
新化合物JBIR-23诱导恶性间皮瘤细胞微管蛋白聚合和凋亡
DOI:
--
发表时间:
2011
期刊:
Cancer letters
影响因子:
9.7
作者:
[Arai A, Imadome K, Wang L, Wu N, Kurosu T, Wake A, Yamamoto H, Ota Y, Harigai M, Fujiwara S, Miura O., Hideki Murakami, Ji-Hwan Hwang]
通讯作者:
Ji-Hwan Hwang
TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth.
DOI:
10.1084/jem.20111653
发表时间:
2012-03-12
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Fujii M, Toyoda T, Nakanishi H, Yatabe Y, Sato A, Matsudaira Y, Ito H, Murakami H, Kondo Y, Kondo E, Hida T, Tsujimura T, Osada H, Sekido Y]
通讯作者:
Sekido Y
An econometric research on market conduct and performance of Us and Japanese low-cost carriers
-
批准号:21530219
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:MURAKAMI Hideki
-
依托单位:
Molecular analysis of the NF2 tumor suppressor gene in malignant mesothelioma
-
批准号:19590421
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:MURAKAMI Hideki
-
依托单位:
Formation and characterization of La2O3 gate dielectrics formed using by metalorganic CVD
-
批准号:19760219
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.27万
-
财政年份:2007
-
负责人:MURAKAMI Hideki
-
依托单位:
An empirical analysis of the market behavior and performance international logistics providers
-
批准号:19530384
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2007
-
负责人:MURAKAMI Hideki
-
依托单位:
An Econometric Analysis of the Impact of Low-cost Carrier's entry on Regional and National Economy : The case of the US and Japan
-
批准号:15530284
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2003
-
负责人:MURAKAMI Hideki
-
依托单位:
海外基金